{"id":9740,"date":"2019-01-22T14:18:29","date_gmt":"2019-01-22T13:18:29","guid":{"rendered":"https:\/\/udic.es\/?page_id=9740"},"modified":"2019-11-08T09:46:58","modified_gmt":"2019-11-08T08:46:58","slug":"blog-news","status":"publish","type":"page","link":"https:\/\/udic.es\/en\/blog-news\/","title":{"rendered":"Blog News"},"content":{"rendered":"<div class=\"row \"><div class=\"wpv-grid grid-1-1  wpv-first-level first unextended\" style=\"padding-top:0px;padding-bottom:0px\" id=\"wpv-column-1814e7fe02a5e070c4ef5ba6362720f6\" >\t\t<div class=\"sep-text single centered\">\n\t\t\t\t\t\t\t<span class=\"sep-text-before\"><div class=\"sep-text-line\"><\/div><\/span>\n\t\t\t\t\t\t<div class=\"content\">\n\t\t\t\t<h2 class=\"text-divider-double\"> Our blog<\/h2>\t\t\t<\/div>\n\t\t\t<span class=\"sep-text-after\"><div class=\"sep-text-line\"><\/div><\/span>\n\t\t\t\t\t<\/div>\n\t<div class=\"loop-wrapper clearfix news row small paginated\" data-columns=\"3\"  >\n\t\t<div class=\"page-content post-header grid-1-3 clearboth list-item post-15680 post type-post status-publish format-standard has-post-thumbnail hentry category-parkinson-en\" itemscope=\"itemscope\" itemtype=\"http:\/\/schema.org\/BlogPosting\">\n\t\t\t<div>\n\t\t\t\t<div class=\"post-article has-image-wrapper \">\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemid=\"https:\/\/udic.es\/en\/an-option-to-modify-the-course-of-parkinsons-progression\/\" \/><meta itemprop=\"datePublished\" content=\"2023-11-21\" \/><meta itemprop=\"dateModified\" content=\"2024-02-14\" \/><meta itemprop=\"headline\" content=\"An option to modify the course of Parkinson&#8217;s progression\" \/><div itemprop=\"publisher\" itemscope itemtype=\"https:\/\/schema.org\/Organization\"><meta itemprop=\"name\" content=\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/\"><div itemprop=\"logo\" itemscope itemtype=\"https:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/marca-udic-web-1.png\"><\/div><\/div><div itemscope itemprop=\"author\" itemtype=\"http:\/\/schema.org\/Person\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/author\/anais\/\" \/><meta itemprop=\"name\" content=\"Anais\" \/><\/div><div itemscope itemprop=\"image\" itemtype=\"http:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\" \/><meta itemprop=\"width\" content=\"815\" \/><meta itemprop=\"height\" content=\"246\" \/><\/div><div itemprop=\"interactionStatistic\" itemscope itemtype=\"http:\/\/schema.org\/InteractionCounter\"><meta itemprop=\"interactionType\" content=\"http:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/><\/div>\t<div class=\"standard-post-format clearfix as-image \">\n\t\t\t<div class=\"thumbnail\">\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"360\" height=\"109\" src=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\" class=\"attachment-post-small-3 size-post-small-3 wp-post-image\" alt=\"logo\" srcset=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png 815w, https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo-300x91.png 300w, https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo-768x232.png 768w\" sizes=\"auto, (min-width: 900px) 50vw, 100vw\" \/>\t\t\t<\/div>\n\n\t<div class=\"post-content-wrapper\">\n\t\t\t\t<header class=\"single\">\n\t\t\t<div class=\"content\">\n\t\t\t\t<h3>\n\t\t\t\t\t<a href=\"https:\/\/udic.es\/en\/an-option-to-modify-the-course-of-parkinsons-progression\/\" title=\"An option to modify the course of Parkinson&#8217;s progression\" class=\"entry-title\">An option to modify the course of Parkinson&#8217;s progression<\/a>\n\t\t\t\t<\/h3>\n\t\t\t<\/div>\n\t\t<\/header>\n\t\n\t\t<div class=\"post-actions-wrapper\">\n\t\t\t\t\t\t\t<div class=\"post-date\">\n\t\t\t\t\t21 de November de 2023\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t<div class=\"post-content-outer\">\n\t\t\t<p>Evaluation of an inhibitor of the LRRK 2 gene in Parkinson&#8217;s patients. Oral tract. We&#8230;<\/p>\n\t\t<\/div>\n\n\t\t\t\t\t<div class=\"post-content-meta\">\n\t\t\t\t<div>\n\t\t\t\t\tPosted in:  <a href=\"https:\/\/udic.es\/en\/category\/parkinson-en\/\" rel=\"category tag\">Parkinson<\/a>\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t<\/div>\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"page-content post-header grid-1-3 list-item post-15677 post type-post status-publish format-standard has-post-thumbnail hentry category-parkinson-en\" itemscope=\"itemscope\" itemtype=\"http:\/\/schema.org\/BlogPosting\">\n\t\t\t<div>\n\t\t\t\t<div class=\"post-article has-image-wrapper \">\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemid=\"https:\/\/udic.es\/en\/an-option-for-patients-with-parkinsons-and-lrrk2-mutation-2\/\" \/><meta itemprop=\"datePublished\" content=\"2023-11-21\" \/><meta itemprop=\"dateModified\" content=\"2024-02-14\" \/><meta itemprop=\"headline\" content=\"An option for patients with Parkinson&#8217;s and LRRK2 mutation\" \/><div itemprop=\"publisher\" itemscope itemtype=\"https:\/\/schema.org\/Organization\"><meta itemprop=\"name\" content=\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/\"><div itemprop=\"logo\" itemscope itemtype=\"https:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/marca-udic-web-1.png\"><\/div><\/div><div itemscope itemprop=\"author\" itemtype=\"http:\/\/schema.org\/Person\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/author\/anais\/\" \/><meta itemprop=\"name\" content=\"Anais\" \/><\/div><div itemscope itemprop=\"image\" itemtype=\"http:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\" \/><meta itemprop=\"width\" content=\"815\" \/><meta itemprop=\"height\" content=\"246\" \/><\/div><div itemprop=\"interactionStatistic\" itemscope itemtype=\"http:\/\/schema.org\/InteractionCounter\"><meta itemprop=\"interactionType\" content=\"http:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/><\/div>\t<div class=\"standard-post-format clearfix as-image \">\n\t\t\t<div class=\"thumbnail\">\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"360\" height=\"109\" src=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\" class=\"attachment-post-small-3 size-post-small-3 wp-post-image\" alt=\"logo\" srcset=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png 815w, https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo-300x91.png 300w, https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo-768x232.png 768w\" sizes=\"auto, (min-width: 900px) 50vw, 100vw\" \/>\t\t\t<\/div>\n\n\t<div class=\"post-content-wrapper\">\n\t\t\t\t<header class=\"single\">\n\t\t\t<div class=\"content\">\n\t\t\t\t<h3>\n\t\t\t\t\t<a href=\"https:\/\/udic.es\/en\/an-option-for-patients-with-parkinsons-and-lrrk2-mutation-2\/\" title=\"An option for patients with Parkinson&#8217;s and LRRK2 mutation\" class=\"entry-title\">An option for patients with Parkinson&#8217;s and LRRK2 mutation<\/a>\n\t\t\t\t<\/h3>\n\t\t\t<\/div>\n\t\t<\/header>\n\t\n\t\t<div class=\"post-actions-wrapper\">\n\t\t\t\t\t\t\t<div class=\"post-date\">\n\t\t\t\t\t21 de November de 2023\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t<div class=\"post-content-outer\">\n\t\t\t<p>Trial on LRRK2 mutation in Parkinson&#8217;s is about to be completed. Our Trials Unit is&#8230;<\/p>\n\t\t<\/div>\n\n\t\t\t\t\t<div class=\"post-content-meta\">\n\t\t\t\t<div>\n\t\t\t\t\tPosted in:  <a href=\"https:\/\/udic.es\/en\/category\/parkinson-en\/\" rel=\"category tag\">Parkinson<\/a>\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t<\/div>\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"page-content post-header grid-1-3 list-item post-15658 post type-post status-publish format-standard has-post-thumbnail hentry category-uncategorised\" itemscope=\"itemscope\" itemtype=\"http:\/\/schema.org\/BlogPosting\">\n\t\t\t<div>\n\t\t\t\t<div class=\"post-article has-image-wrapper \">\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemid=\"https:\/\/udic.es\/en\/an-option-for-patients-with-parkinsons-and-lrrk2-mutation\/\" \/><meta itemprop=\"datePublished\" content=\"2023-11-21\" \/><meta itemprop=\"dateModified\" content=\"2023-11-21\" \/><meta itemprop=\"headline\" content=\"An option for patients with Parkinson&#8217;s and LRRK2 mutation\" \/><div itemprop=\"publisher\" itemscope itemtype=\"https:\/\/schema.org\/Organization\"><meta itemprop=\"name\" content=\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/\"><div itemprop=\"logo\" itemscope itemtype=\"https:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/marca-udic-web-1.png\"><\/div><\/div><div itemscope itemprop=\"author\" itemtype=\"http:\/\/schema.org\/Person\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/author\/anais\/\" \/><meta itemprop=\"name\" content=\"Anais\" \/><\/div><div itemscope itemprop=\"image\" itemtype=\"http:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\" \/><meta itemprop=\"width\" content=\"815\" \/><meta itemprop=\"height\" content=\"246\" \/><\/div><div itemprop=\"interactionStatistic\" itemscope itemtype=\"http:\/\/schema.org\/InteractionCounter\"><meta itemprop=\"interactionType\" content=\"http:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/><\/div>\t<div class=\"standard-post-format clearfix as-image \">\n\t\t\t<div class=\"thumbnail\">\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"360\" height=\"109\" src=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\" class=\"attachment-post-small-3 size-post-small-3 wp-post-image\" alt=\"logo\" srcset=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png 815w, https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo-300x91.png 300w, https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo-768x232.png 768w\" sizes=\"auto, (min-width: 900px) 50vw, 100vw\" \/>\t\t\t<\/div>\n\n\t<div class=\"post-content-wrapper\">\n\t\t\t\t<header class=\"single\">\n\t\t\t<div class=\"content\">\n\t\t\t\t<h3>\n\t\t\t\t\t<a href=\"https:\/\/udic.es\/en\/an-option-for-patients-with-parkinsons-and-lrrk2-mutation\/\" title=\"An option for patients with Parkinson&#8217;s and LRRK2 mutation\" class=\"entry-title\">An option for patients with Parkinson&#8217;s and LRRK2 mutation<\/a>\n\t\t\t\t<\/h3>\n\t\t\t<\/div>\n\t\t<\/header>\n\t\n\t\t<div class=\"post-actions-wrapper\">\n\t\t\t\t\t\t\t<div class=\"post-date\">\n\t\t\t\t\t21 de November de 2023\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t<div class=\"post-content-outer\">\n\t\t\t<p>Trial on LRRK2 mutation in Parkinson&#8217;s disease is about to be completed. Our Clinical Trials&#8230;<\/p>\n\t\t<\/div>\n\n\t\t\t\t\t<div class=\"post-content-meta\">\n\t\t\t\t<div>\n\t\t\t\t\tPosted in:  <a href=\"https:\/\/udic.es\/en\/category\/uncategorised\/\" rel=\"category tag\">Uncategorised<\/a>\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t<\/div>\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"page-content post-header grid-1-3 clearboth list-item post-14146 post type-post status-publish format-standard has-post-thumbnail hentry category-parkinson-en\" itemscope=\"itemscope\" itemtype=\"http:\/\/schema.org\/BlogPosting\">\n\t\t\t<div>\n\t\t\t\t<div class=\"post-article has-image-wrapper \">\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemid=\"https:\/\/udic.es\/en\/positive-result-from-the-pivotal-trial-with-levodopa-administered-by-continuous-subcutaneous-infusion\/\" \/><meta itemprop=\"datePublished\" content=\"2023-05-08\" \/><meta itemprop=\"dateModified\" content=\"2024-02-14\" \/><meta itemprop=\"headline\" content=\"Positive result from the Pivotal trial with levodopa administered by continuous subcutaneous infusion\" \/><div itemprop=\"publisher\" itemscope itemtype=\"https:\/\/schema.org\/Organization\"><meta itemprop=\"name\" content=\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/\"><div itemprop=\"logo\" itemscope itemtype=\"https:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/marca-udic-web-1.png\"><\/div><\/div><div itemscope itemprop=\"author\" itemtype=\"http:\/\/schema.org\/Person\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/author\/anais\/\" \/><meta itemprop=\"name\" content=\"Anais\" \/><\/div><div itemscope itemprop=\"image\" itemtype=\"http:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\" \/><meta itemprop=\"width\" content=\"815\" \/><meta itemprop=\"height\" content=\"246\" \/><\/div><div itemprop=\"interactionStatistic\" itemscope itemtype=\"http:\/\/schema.org\/InteractionCounter\"><meta itemprop=\"interactionType\" content=\"http:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/><\/div>\t<div class=\"standard-post-format clearfix as-image \">\n\t\t\t<div class=\"thumbnail\">\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"360\" height=\"109\" src=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\" class=\"attachment-post-small-3 size-post-small-3 wp-post-image\" alt=\"logo\" srcset=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png 815w, https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo-300x91.png 300w, https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo-768x232.png 768w\" sizes=\"auto, (min-width: 900px) 50vw, 100vw\" \/>\t\t\t<\/div>\n\n\t<div class=\"post-content-wrapper\">\n\t\t\t\t<header class=\"single\">\n\t\t\t<div class=\"content\">\n\t\t\t\t<h3>\n\t\t\t\t\t<a href=\"https:\/\/udic.es\/en\/positive-result-from-the-pivotal-trial-with-levodopa-administered-by-continuous-subcutaneous-infusion\/\" title=\"Positive result from the Pivotal trial with levodopa administered by continuous subcutaneous infusion\" class=\"entry-title\">Positive result from the Pivotal trial with levodopa administered by continuous subcutaneous infusion<\/a>\n\t\t\t\t<\/h3>\n\t\t\t<\/div>\n\t\t<\/header>\n\t\n\t\t<div class=\"post-actions-wrapper\">\n\t\t\t\t\t\t\t<div class=\"post-date\">\n\t\t\t\t\t8 de May de 2023\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t<div class=\"post-content-outer\">\n\t\t\t<p>Highly positive results from the pivotal Phase III BouNDless trial evaluating ND0612 in patients with&#8230;<\/p>\n\t\t<\/div>\n\n\t\t\t\t\t<div class=\"post-content-meta\">\n\t\t\t\t<div>\n\t\t\t\t\tPosted in:  <a href=\"https:\/\/udic.es\/en\/category\/parkinson-en\/\" rel=\"category tag\">Parkinson<\/a>\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t<\/div>\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"page-content post-header grid-1-3 list-item post-14125 post type-post status-publish format-standard has-post-thumbnail hentry category-parkinson-en\" itemscope=\"itemscope\" itemtype=\"http:\/\/schema.org\/BlogPosting\">\n\t\t\t<div>\n\t\t\t\t<div class=\"post-article has-image-wrapper \">\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemid=\"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/\" \/><meta itemprop=\"datePublished\" content=\"2023-05-08\" \/><meta itemprop=\"dateModified\" content=\"2024-02-14\" \/><meta itemprop=\"headline\" content=\"New inhaled levodopa INBRIJA authorised in Spain\" \/><div itemprop=\"publisher\" itemscope itemtype=\"https:\/\/schema.org\/Organization\"><meta itemprop=\"name\" content=\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/\"><div itemprop=\"logo\" itemscope itemtype=\"https:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/marca-udic-web-1.png\"><\/div><\/div><div itemscope itemprop=\"author\" itemtype=\"http:\/\/schema.org\/Person\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/author\/anais\/\" \/><meta itemprop=\"name\" content=\"Anais\" \/><\/div><div itemscope itemprop=\"image\" itemtype=\"http:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\" \/><meta itemprop=\"width\" content=\"815\" \/><meta itemprop=\"height\" content=\"246\" \/><\/div><div itemprop=\"interactionStatistic\" itemscope itemtype=\"http:\/\/schema.org\/InteractionCounter\"><meta itemprop=\"interactionType\" content=\"http:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/><\/div>\t<div class=\"standard-post-format clearfix as-image \">\n\t\t\t<div class=\"thumbnail\">\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"360\" height=\"109\" src=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\" class=\"attachment-post-small-3 size-post-small-3 wp-post-image\" alt=\"logo\" srcset=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png 815w, https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo-300x91.png 300w, https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo-768x232.png 768w\" sizes=\"auto, (min-width: 900px) 50vw, 100vw\" \/>\t\t\t<\/div>\n\n\t<div class=\"post-content-wrapper\">\n\t\t\t\t<header class=\"single\">\n\t\t\t<div class=\"content\">\n\t\t\t\t<h3>\n\t\t\t\t\t<a href=\"https:\/\/udic.es\/en\/new-inhaled-levodopa-inbrija-authorised-in-spain\/\" title=\"New inhaled levodopa INBRIJA authorised in Spain\" class=\"entry-title\">New inhaled levodopa INBRIJA authorised in Spain<\/a>\n\t\t\t\t<\/h3>\n\t\t\t<\/div>\n\t\t<\/header>\n\t\n\t\t<div class=\"post-actions-wrapper\">\n\t\t\t\t\t\t\t<div class=\"post-date\">\n\t\t\t\t\t8 de May de 2023\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t<div class=\"post-content-outer\">\n\t\t\t<p>The new formulation of inhaled levodopa, Inbrija, has been approved for marketing in Spain. Manufactured&#8230;<\/p>\n\t\t<\/div>\n\n\t\t\t\t\t<div class=\"post-content-meta\">\n\t\t\t\t<div>\n\t\t\t\t\tPosted in:  <a href=\"https:\/\/udic.es\/en\/category\/parkinson-en\/\" rel=\"category tag\">Parkinson<\/a>\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t<\/div>\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"page-content post-header grid-1-3 list-item post-13649 post type-post status-publish format-standard has-post-thumbnail hentry category-alzeimer-en category-alzeimer-2 category-news category-uncategorised\" itemscope=\"itemscope\" itemtype=\"http:\/\/schema.org\/BlogPosting\">\n\t\t\t<div>\n\t\t\t\t<div class=\"post-article has-image-wrapper \">\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemid=\"https:\/\/udic.es\/en\/new-drug-for-early-stage-alzheimers-disease\/\" \/><meta itemprop=\"datePublished\" content=\"2023-01-16\" \/><meta itemprop=\"dateModified\" content=\"2024-02-16\" \/><meta itemprop=\"headline\" content=\"new drug for early-stage Alzheimer&#8217;s disease\" \/><div itemprop=\"publisher\" itemscope itemtype=\"https:\/\/schema.org\/Organization\"><meta itemprop=\"name\" content=\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/\"><div itemprop=\"logo\" itemscope itemtype=\"https:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/marca-udic-web-1.png\"><\/div><\/div><div itemscope itemprop=\"author\" itemtype=\"http:\/\/schema.org\/Person\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/author\/tito\/\" \/><meta itemprop=\"name\" content=\"Tito Surribas\" \/><\/div><div itemscope itemprop=\"image\" itemtype=\"http:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Area-privada5.jpg\" \/><meta itemprop=\"width\" content=\"5056\" \/><meta itemprop=\"height\" content=\"1752\" \/><\/div><div itemprop=\"interactionStatistic\" itemscope itemtype=\"http:\/\/schema.org\/InteractionCounter\"><meta itemprop=\"interactionType\" content=\"http:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/><\/div>\t<div class=\"standard-post-format clearfix as-image \">\n\t\t\t<div class=\"thumbnail\">\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"360\" height=\"276\" src=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Area-privada5-360x276.jpg\" class=\"attachment-post-small-3 size-post-small-3 wp-post-image\" alt=\"Area privada5\" srcset=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Area-privada5-360x276.jpg 360w, https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Area-privada5-480x369.jpg 480w, https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Area-privada5-1140x876.jpg 1140w, https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Area-privada5-555x426.jpg 555w, https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Area-privada5-262x201.jpg 262w\" sizes=\"auto, (min-width: 900px) 50vw, 100vw\" \/>\t\t\t<\/div>\n\n\t<div class=\"post-content-wrapper\">\n\t\t\t\t<header class=\"single\">\n\t\t\t<div class=\"content\">\n\t\t\t\t<h3>\n\t\t\t\t\t<a href=\"https:\/\/udic.es\/en\/new-drug-for-early-stage-alzheimers-disease\/\" title=\"new drug for early-stage Alzheimer&#8217;s disease\" class=\"entry-title\">new drug for early-stage Alzheimer&#8217;s disease<\/a>\n\t\t\t\t<\/h3>\n\t\t\t<\/div>\n\t\t<\/header>\n\t\n\t\t<div class=\"post-actions-wrapper\">\n\t\t\t\t\t\t\t<div class=\"post-date\">\n\t\t\t\t\t16 de January de 2023\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t<div class=\"post-content-outer\">\n\t\t\t<p>On Epiphany, the U.S. Food and Drug Administration approved a new drug for early-stage Alzheimer&#8217;s&#8230;<\/p>\n\t\t<\/div>\n\n\t\t\t\t\t<div class=\"post-content-meta\">\n\t\t\t\t<div>\n\t\t\t\t\tPosted in:  <a href=\"https:\/\/udic.es\/en\/category\/alzeimer-en\/\" rel=\"category tag\">Alzeimer<\/a>, <a href=\"https:\/\/udic.es\/en\/category\/alzeimer-2\/\" rel=\"category tag\">Alzeimer<\/a>, <a href=\"https:\/\/udic.es\/en\/category\/news\/\" rel=\"category tag\">News<\/a>, <a href=\"https:\/\/udic.es\/en\/category\/uncategorised\/\" rel=\"category tag\">Uncategorised<\/a>\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t<\/div>\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"page-content post-header grid-1-3 clearboth list-item post-11951 post type-post status-publish format-standard has-post-thumbnail hentry category-alzeimer-en category-uncategorised\" itemscope=\"itemscope\" itemtype=\"http:\/\/schema.org\/BlogPosting\">\n\t\t\t<div>\n\t\t\t\t<div class=\"post-article has-image-wrapper \">\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemid=\"https:\/\/udic.es\/en\/we-tested-a-drug-to-treat-agitation-in-alzheimers-patients\/\" \/><meta itemprop=\"datePublished\" content=\"2021-06-03\" \/><meta itemprop=\"dateModified\" content=\"2021-06-03\" \/><meta itemprop=\"headline\" content=\"We tested a drug to treat agitation in Alzheimer&#8217;s patients\" \/><div itemprop=\"publisher\" itemscope itemtype=\"https:\/\/schema.org\/Organization\"><meta itemprop=\"name\" content=\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/\"><div itemprop=\"logo\" itemscope itemtype=\"https:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/marca-udic-web-1.png\"><\/div><\/div><div itemscope itemprop=\"author\" itemtype=\"http:\/\/schema.org\/Person\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/author\/susana-andrade\/\" \/><meta itemprop=\"name\" content=\"SUSANA ANDRADE\" \/><\/div><div itemscope itemprop=\"image\" itemtype=\"http:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Area-privada1.jpg\" \/><meta itemprop=\"width\" content=\"5056\" \/><meta itemprop=\"height\" content=\"1752\" \/><\/div><div itemprop=\"interactionStatistic\" itemscope itemtype=\"http:\/\/schema.org\/InteractionCounter\"><meta itemprop=\"interactionType\" content=\"http:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/><\/div>\t<div class=\"standard-post-format clearfix as-image \">\n\t\t\t<div class=\"thumbnail\">\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"360\" height=\"276\" src=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Area-privada1-360x276.jpg\" class=\"attachment-post-small-3 size-post-small-3 wp-post-image\" alt=\"Area privada1\" srcset=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Area-privada1-360x276.jpg 360w, https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Area-privada1-480x369.jpg 480w, https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Area-privada1-1140x876.jpg 1140w, https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Area-privada1-555x426.jpg 555w, https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Area-privada1-262x201.jpg 262w\" sizes=\"auto, (min-width: 900px) 50vw, 100vw\" \/>\t\t\t<\/div>\n\n\t<div class=\"post-content-wrapper\">\n\t\t\t\t<header class=\"single\">\n\t\t\t<div class=\"content\">\n\t\t\t\t<h3>\n\t\t\t\t\t<a href=\"https:\/\/udic.es\/en\/we-tested-a-drug-to-treat-agitation-in-alzheimers-patients\/\" title=\"We tested a drug to treat agitation in Alzheimer&#8217;s patients\" class=\"entry-title\">We tested a drug to treat agitation in Alzheimer&#8217;s patients<\/a>\n\t\t\t\t<\/h3>\n\t\t\t<\/div>\n\t\t<\/header>\n\t\n\t\t<div class=\"post-actions-wrapper\">\n\t\t\t\t\t\t\t<div class=\"post-date\">\n\t\t\t\t\t3 de June de 2021\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t<div class=\"post-content-outer\">\n\t\t\t<p>The General University Hospital of Catalonia is the first recognized center in Europe to evaluate&#8230;<\/p>\n\t\t<\/div>\n\n\t\t\t\t\t<div class=\"post-content-meta\">\n\t\t\t\t<div>\n\t\t\t\t\tPosted in:  <a href=\"https:\/\/udic.es\/en\/category\/alzeimer-en\/\" rel=\"category tag\">Alzeimer<\/a>, <a href=\"https:\/\/udic.es\/en\/category\/uncategorised\/\" rel=\"category tag\">Uncategorised<\/a>\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t<\/div>\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"page-content post-header grid-1-3 list-item post-11944 post type-post status-publish format-standard has-post-thumbnail hentry category-alzeimer-2 category-uncategorised\" itemscope=\"itemscope\" itemtype=\"http:\/\/schema.org\/BlogPosting\">\n\t\t\t<div>\n\t\t\t\t<div class=\"post-article has-image-wrapper \">\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemid=\"https:\/\/udic.es\/en\/la-udic-ha-inclos-el-primer-pacient-del-mon-en-un-assaig-clinic-de-fase-i-sobre-lalzheimer\/\" \/><meta itemprop=\"datePublished\" content=\"2021-06-03\" \/><meta itemprop=\"dateModified\" content=\"2024-02-14\" \/><meta itemprop=\"headline\" content=\"The General University Hospital of Catalonia (HUGC), through the Clinical Research Unit (UDIC), has included the world&#8217;s first patient in a phase I clinical trial on Alzheimer&#8217;s.\" \/><div itemprop=\"publisher\" itemscope itemtype=\"https:\/\/schema.org\/Organization\"><meta itemprop=\"name\" content=\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/\"><div itemprop=\"logo\" itemscope itemtype=\"https:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/marca-udic-web-1.png\"><\/div><\/div><div itemscope itemprop=\"author\" itemtype=\"http:\/\/schema.org\/Person\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/author\/tito\/\" \/><meta itemprop=\"name\" content=\"Tito Surribas\" \/><\/div><div itemscope itemprop=\"image\" itemtype=\"http:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2019\/03\/Blogudic1.jpg\" \/><meta itemprop=\"width\" content=\"1181\" \/><meta itemprop=\"height\" content=\"591\" \/><\/div><div itemprop=\"interactionStatistic\" itemscope itemtype=\"http:\/\/schema.org\/InteractionCounter\"><meta itemprop=\"interactionType\" content=\"http:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/><\/div>\t<div class=\"standard-post-format clearfix as-image \">\n\t\t\t<div class=\"thumbnail\">\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"360\" height=\"276\" src=\"https:\/\/udic.es\/wp-content\/uploads\/2019\/03\/Blogudic1-360x276.jpg\" class=\"attachment-post-small-3 size-post-small-3 wp-post-image\" alt=\"Blogudic1\" srcset=\"https:\/\/udic.es\/wp-content\/uploads\/2019\/03\/Blogudic1-360x276.jpg 360w, https:\/\/udic.es\/wp-content\/uploads\/2019\/03\/Blogudic1-480x369.jpg 480w, https:\/\/udic.es\/wp-content\/uploads\/2019\/03\/Blogudic1-555x426.jpg 555w, https:\/\/udic.es\/wp-content\/uploads\/2019\/03\/Blogudic1-262x201.jpg 262w\" sizes=\"auto, (min-width: 900px) 50vw, 100vw\" \/>\t\t\t<\/div>\n\n\t<div class=\"post-content-wrapper\">\n\t\t\t\t<header class=\"single\">\n\t\t\t<div class=\"content\">\n\t\t\t\t<h3>\n\t\t\t\t\t<a href=\"https:\/\/udic.es\/en\/la-udic-ha-inclos-el-primer-pacient-del-mon-en-un-assaig-clinic-de-fase-i-sobre-lalzheimer\/\" title=\"The General University Hospital of Catalonia (HUGC), through the Clinical Research Unit (UDIC), has included the world&#8217;s first patient in a phase I clinical trial on Alzheimer&#8217;s.\" class=\"entry-title\">The General University Hospital of Catalonia (HUGC), through the Clinical Research Unit (UDIC), has included the world&#8217;s first patient in a phase I clinical trial on Alzheimer&#8217;s.<\/a>\n\t\t\t\t<\/h3>\n\t\t\t<\/div>\n\t\t<\/header>\n\t\n\t\t<div class=\"post-actions-wrapper\">\n\t\t\t\t\t\t\t<div class=\"post-date\">\n\t\t\t\t\t3 de June de 2021\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t<div class=\"post-content-outer\">\n\t\t\t<p>This study could improve the efficacy and safety of the products being evaluated to try&#8230;<\/p>\n\t\t<\/div>\n\n\t\t\t\t\t<div class=\"post-content-meta\">\n\t\t\t\t<div>\n\t\t\t\t\tPosted in:  <a href=\"https:\/\/udic.es\/en\/category\/alzeimer-2\/\" rel=\"category tag\">Alzeimer<\/a>, <a href=\"https:\/\/udic.es\/en\/category\/uncategorised\/\" rel=\"category tag\">Uncategorised<\/a>\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t<\/div>\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"page-content post-header grid-1-3 list-item post-11349 post type-post status-publish format-standard has-post-thumbnail hentry category-parkinson-en category-uncategorised\" itemscope=\"itemscope\" itemtype=\"http:\/\/schema.org\/BlogPosting\">\n\t\t\t<div>\n\t\t\t\t<div class=\"post-article has-image-wrapper \">\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemid=\"https:\/\/udic.es\/en\/fda-approves-sublingual-apomorphine-in-off-periods\/\" \/><meta itemprop=\"datePublished\" content=\"2020-07-22\" \/><meta itemprop=\"dateModified\" content=\"2020-07-23\" \/><meta itemprop=\"headline\" content=\"FDA approves sublingual apomorphine in off periods\" \/><div itemprop=\"publisher\" itemscope itemtype=\"https:\/\/schema.org\/Organization\"><meta itemprop=\"name\" content=\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/\"><div itemprop=\"logo\" itemscope itemtype=\"https:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/marca-udic-web-1.png\"><\/div><\/div><div itemscope itemprop=\"author\" itemtype=\"http:\/\/schema.org\/Person\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/author\/susana-andrade\/\" \/><meta itemprop=\"name\" content=\"SUSANA ANDRADE\" \/><\/div><div itemscope itemprop=\"image\" itemtype=\"http:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\" \/><meta itemprop=\"width\" content=\"815\" \/><meta itemprop=\"height\" content=\"246\" \/><\/div><div itemprop=\"interactionStatistic\" itemscope itemtype=\"http:\/\/schema.org\/InteractionCounter\"><meta itemprop=\"interactionType\" content=\"http:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/><\/div>\t<div class=\"standard-post-format clearfix as-image \">\n\t\t\t<div class=\"thumbnail\">\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"360\" height=\"109\" src=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png\" class=\"attachment-post-small-3 size-post-small-3 wp-post-image\" alt=\"logo\" srcset=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo.png 815w, https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo-300x91.png 300w, https:\/\/udic.es\/wp-content\/uploads\/2017\/07\/logo-768x232.png 768w\" sizes=\"auto, (min-width: 900px) 50vw, 100vw\" \/>\t\t\t<\/div>\n\n\t<div class=\"post-content-wrapper\">\n\t\t\t\t<header class=\"single\">\n\t\t\t<div class=\"content\">\n\t\t\t\t<h3>\n\t\t\t\t\t<a href=\"https:\/\/udic.es\/en\/fda-approves-sublingual-apomorphine-in-off-periods\/\" title=\"FDA approves sublingual apomorphine in off periods\" class=\"entry-title\">FDA approves sublingual apomorphine in off periods<\/a>\n\t\t\t\t<\/h3>\n\t\t\t<\/div>\n\t\t<\/header>\n\t\n\t\t<div class=\"post-actions-wrapper\">\n\t\t\t\t\t\t\t<div class=\"post-date\">\n\t\t\t\t\t22 de July de 2020\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t<div class=\"post-content-outer\">\n\t\t\t<p>The FDA has approved the use of sublingual apomorphine (KYNMOBI) in motor blocks, in Parkinson&#8217;s&#8230;<\/p>\n\t\t<\/div>\n\n\t\t\t\t\t<div class=\"post-content-meta\">\n\t\t\t\t<div>\n\t\t\t\t\tPosted in:  <a href=\"https:\/\/udic.es\/en\/category\/parkinson-en\/\" rel=\"category tag\">Parkinson<\/a>, <a href=\"https:\/\/udic.es\/en\/category\/uncategorised\/\" rel=\"category tag\">Uncategorised<\/a>\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t<\/div>\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"page-content post-header grid-1-3 clearboth list-item post-11099 post type-post status-publish format-standard has-post-thumbnail hentry category-parkinson-en\" itemscope=\"itemscope\" itemtype=\"http:\/\/schema.org\/BlogPosting\">\n\t\t\t<div>\n\t\t\t\t<div class=\"post-article has-image-wrapper \">\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemid=\"https:\/\/udic.es\/en\/autorizada-en-eeuu-una-levodopa-intranasal\/\" \/><meta itemprop=\"datePublished\" content=\"2020-04-08\" \/><meta itemprop=\"dateModified\" content=\"2024-02-16\" \/><meta itemprop=\"headline\" content=\"US authorizes an intranasal levodopa.\" \/><div itemprop=\"publisher\" itemscope itemtype=\"https:\/\/schema.org\/Organization\"><meta itemprop=\"name\" content=\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/\"><div itemprop=\"logo\" itemscope itemtype=\"https:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/marca-udic-web-1.png\"><\/div><\/div><div itemscope itemprop=\"author\" itemtype=\"http:\/\/schema.org\/Person\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/author\/susana-andrade\/\" \/><meta itemprop=\"name\" content=\"SUSANA ANDRADE\" \/><\/div><div itemscope itemprop=\"image\" itemtype=\"http:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/10\/nota-legal.jpg\" \/><meta itemprop=\"width\" content=\"5056\" \/><meta itemprop=\"height\" content=\"1752\" \/><\/div><div itemprop=\"interactionStatistic\" itemscope itemtype=\"http:\/\/schema.org\/InteractionCounter\"><meta itemprop=\"interactionType\" content=\"http:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/><\/div>\t<div class=\"standard-post-format clearfix as-image \">\n\t\t\t<div class=\"thumbnail\">\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"360\" height=\"276\" src=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/10\/nota-legal-360x276.jpg\" class=\"attachment-post-small-3 size-post-small-3 wp-post-image\" alt=\"nota legal\" srcset=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/10\/nota-legal-360x276.jpg 360w, https:\/\/udic.es\/wp-content\/uploads\/2017\/10\/nota-legal-480x369.jpg 480w, https:\/\/udic.es\/wp-content\/uploads\/2017\/10\/nota-legal-1140x876.jpg 1140w, https:\/\/udic.es\/wp-content\/uploads\/2017\/10\/nota-legal-555x426.jpg 555w, https:\/\/udic.es\/wp-content\/uploads\/2017\/10\/nota-legal-262x201.jpg 262w\" sizes=\"auto, (min-width: 900px) 50vw, 100vw\" \/>\t\t\t<\/div>\n\n\t<div class=\"post-content-wrapper\">\n\t\t\t\t<header class=\"single\">\n\t\t\t<div class=\"content\">\n\t\t\t\t<h3>\n\t\t\t\t\t<a href=\"https:\/\/udic.es\/en\/autorizada-en-eeuu-una-levodopa-intranasal\/\" title=\"US authorizes an intranasal levodopa.\" class=\"entry-title\">US authorizes an intranasal levodopa.<\/a>\n\t\t\t\t<\/h3>\n\t\t\t<\/div>\n\t\t<\/header>\n\t\n\t\t<div class=\"post-actions-wrapper\">\n\t\t\t\t\t\t\t<div class=\"post-date\">\n\t\t\t\t\t8 de April de 2020\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t<div class=\"post-content-outer\">\n\t\t\t<p>An intranasal levodopa has been authorized in the US to treat off blockages, called Inbrija&#8230;.<\/p>\n\t\t<\/div>\n\n\t\t\t\t\t<div class=\"post-content-meta\">\n\t\t\t\t<div>\n\t\t\t\t\tPosted in:  <a href=\"https:\/\/udic.es\/en\/category\/parkinson-en\/\" rel=\"category tag\">Parkinson<\/a>\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t<\/div>\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"page-content post-header grid-1-3 list-item post-11092 post type-post status-publish format-standard has-post-thumbnail hentry category-parkinson-en\" itemscope=\"itemscope\" itemtype=\"http:\/\/schema.org\/BlogPosting\">\n\t\t\t<div>\n\t\t\t\t<div class=\"post-article has-image-wrapper \">\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemid=\"https:\/\/udic.es\/en\/levodopa-infusion-pump-2\/\" \/><meta itemprop=\"datePublished\" content=\"2020-04-02\" \/><meta itemprop=\"dateModified\" content=\"2024-02-16\" \/><meta itemprop=\"headline\" content=\"Levodopa infusion pump\" \/><div itemprop=\"publisher\" itemscope itemtype=\"https:\/\/schema.org\/Organization\"><meta itemprop=\"name\" content=\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/\"><div itemprop=\"logo\" itemscope itemtype=\"https:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/marca-udic-web-1.png\"><\/div><\/div><div itemscope itemprop=\"author\" itemtype=\"http:\/\/schema.org\/Person\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/author\/tito\/\" \/><meta itemprop=\"name\" content=\"Tito Surribas\" \/><\/div><div itemscope itemprop=\"image\" itemtype=\"http:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1.jpg\" \/><meta itemprop=\"width\" content=\"5056\" \/><meta itemprop=\"height\" content=\"1752\" \/><\/div><div itemprop=\"interactionStatistic\" itemscope itemtype=\"http:\/\/schema.org\/InteractionCounter\"><meta itemprop=\"interactionType\" content=\"http:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/><\/div>\t<div class=\"standard-post-format clearfix as-image \">\n\t\t\t<div class=\"thumbnail\">\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"360\" height=\"276\" src=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1-360x276.jpg\" class=\"attachment-post-small-3 size-post-small-3 wp-post-image\" alt=\"Proyectos1\" srcset=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1-360x276.jpg 360w, https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1-480x369.jpg 480w, https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1-1140x876.jpg 1140w, https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1-555x426.jpg 555w, https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1-262x201.jpg 262w\" sizes=\"auto, (min-width: 900px) 50vw, 100vw\" \/>\t\t\t<\/div>\n\n\t<div class=\"post-content-wrapper\">\n\t\t\t\t<header class=\"single\">\n\t\t\t<div class=\"content\">\n\t\t\t\t<h3>\n\t\t\t\t\t<a href=\"https:\/\/udic.es\/en\/levodopa-infusion-pump-2\/\" title=\"Levodopa infusion pump\" class=\"entry-title\">Levodopa infusion pump<\/a>\n\t\t\t\t<\/h3>\n\t\t\t<\/div>\n\t\t<\/header>\n\t\n\t\t<div class=\"post-actions-wrapper\">\n\t\t\t\t\t\t\t<div class=\"post-date\">\n\t\t\t\t\t2 de April de 2020\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t<div class=\"post-content-outer\">\n\t\t\t<p>Levodopa infusion pump We evaluate an ultraconcentrated levodopa administered subcutaneously in patients with motor fluctuations&#8230;.<\/p>\n\t\t<\/div>\n\n\t\t\t\t\t<div class=\"post-content-meta\">\n\t\t\t\t<div>\n\t\t\t\t\tPosted in:  <a href=\"https:\/\/udic.es\/en\/category\/parkinson-en\/\" rel=\"category tag\">Parkinson<\/a>\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t<\/div>\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"page-content post-header grid-1-3 list-item post-11052 post type-post status-publish format-standard has-post-thumbnail hentry category-parkinson-en\" itemscope=\"itemscope\" itemtype=\"http:\/\/schema.org\/BlogPosting\">\n\t\t\t<div>\n\t\t\t\t<div class=\"post-article has-image-wrapper \">\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemid=\"https:\/\/udic.es\/en\/activation-of-phase-i-trial-in-progressive-supranuclear-paralysis\/\" \/><meta itemprop=\"datePublished\" content=\"2020-03-11\" \/><meta itemprop=\"dateModified\" content=\"2024-02-16\" \/><meta itemprop=\"headline\" content=\"Activation of phase I trial in Progressive Supranuclear Palsy\" \/><div itemprop=\"publisher\" itemscope itemtype=\"https:\/\/schema.org\/Organization\"><meta itemprop=\"name\" content=\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/\"><div itemprop=\"logo\" itemscope itemtype=\"https:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/09\/marca-udic-web-1.png\"><\/div><\/div><div itemscope itemprop=\"author\" itemtype=\"http:\/\/schema.org\/Person\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/en\/author\/susana-andrade\/\" \/><meta itemprop=\"name\" content=\"SUSANA ANDRADE\" \/><\/div><div itemscope itemprop=\"image\" itemtype=\"http:\/\/schema.org\/ImageObject\"><meta itemprop=\"url\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Area-privada1.jpg\" \/><meta itemprop=\"width\" content=\"5056\" \/><meta itemprop=\"height\" content=\"1752\" \/><\/div><div itemprop=\"interactionStatistic\" itemscope itemtype=\"http:\/\/schema.org\/InteractionCounter\"><meta itemprop=\"interactionType\" content=\"http:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/><\/div>\t<div class=\"standard-post-format clearfix as-image \">\n\t\t\t<div class=\"thumbnail\">\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"360\" height=\"276\" src=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Area-privada1-360x276.jpg\" class=\"attachment-post-small-3 size-post-small-3 wp-post-image\" alt=\"Area privada1\" srcset=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Area-privada1-360x276.jpg 360w, https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Area-privada1-480x369.jpg 480w, https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Area-privada1-1140x876.jpg 1140w, https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Area-privada1-555x426.jpg 555w, https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Area-privada1-262x201.jpg 262w\" sizes=\"auto, (min-width: 900px) 50vw, 100vw\" \/>\t\t\t<\/div>\n\n\t<div class=\"post-content-wrapper\">\n\t\t\t\t<header class=\"single\">\n\t\t\t<div class=\"content\">\n\t\t\t\t<h3>\n\t\t\t\t\t<a href=\"https:\/\/udic.es\/en\/activation-of-phase-i-trial-in-progressive-supranuclear-paralysis\/\" title=\"Activation of phase I trial in Progressive Supranuclear Palsy\" class=\"entry-title\">Activation of phase I trial in Progressive Supranuclear Palsy<\/a>\n\t\t\t\t<\/h3>\n\t\t\t<\/div>\n\t\t<\/header>\n\t\n\t\t<div class=\"post-actions-wrapper\">\n\t\t\t\t\t\t\t<div class=\"post-date\">\n\t\t\t\t\t11 de March de 2020\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t<div class=\"post-content-outer\">\n\t\t\t<p>Our Unit has achieved to be activated in this outstanding project and so serious pathology&#8230;.<\/p>\n\t\t<\/div>\n\n\t\t\t\t\t<div class=\"post-content-meta\">\n\t\t\t\t<div>\n\t\t\t\t\tPosted in:  <a href=\"https:\/\/udic.es\/en\/category\/parkinson-en\/\" rel=\"category tag\">Parkinson<\/a>\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t<\/div>\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n<\/div>\n\n<div class=\"wp-pagenavi\"><span class=\"pages\">Page 1 of 4<\/span><span aria-current=\"page\" class=\"page-numbers current\">1<\/span>\n<a class=\"page-numbers\" href=\"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/pages\/9740\/page\/2\/\">2<\/a>\n<a class=\"page-numbers\" href=\"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/pages\/9740\/page\/3\/\">3<\/a>\n<a class=\"page-numbers\" href=\"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/pages\/9740\/page\/4\/\">4<\/a>\n<a class=\"next page-numbers\" href=\"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/pages\/9740\/page\/2\/\">Next<\/a><\/div><\/div><\/div>\n<div class=\"push\" style='height:55px'><\/div>\n\n\t\t\t<!-- START noticiasudic REVOLUTION SLIDER 6.6.14 --><p class=\"rs-p-wp-fix\"><\/p>\n\t\t\t<rs-module-wrap id=\"rev_slider_38_1_wrapper\" data-source=\"gallery\" style=\"visibility:hidden;background:transparent;padding:0;margin:0px auto;margin-top:0;margin-bottom:0;\">\n\t\t\t\t<rs-module id=\"rev_slider_38_1\" style=\"\" data-version=\"6.6.14\">\n\t\t\t\t\t<rs-slides style=\"overflow: hidden; position: absolute;\">\n\t\t\t\t\t\t<rs-slide style=\"position: absolute;\" data-key=\"rs-119\" data-title=\"Slide\" data-duration=\"6020\" data-anim=\"adpr:false;\">\n\t\t\t\t\t\t\t<img decoding=\"async\" src=\"\/\/udic.es\/wp-content\/plugins\/revslider\/public\/assets\/assets\/dummy.png\" alt=\"\" title=\"Activation of phase I trial in Progressive Supranuclear Palsy\" class=\"rev-slidebg tp-rs-img rs-lazyload\" data-lazyload=\"\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos2.jpg\" data-no-retina>\n<!--\n\t\t\t\t\t\t\t--><rs-layer\n\t\t\t\t\t\t\t\tid=\"slider-38-slide-119-layer-6\" \n\t\t\t\t\t\t\t\tclass=\"Gym-Display\"\n\t\t\t\t\t\t\t\tdata-type=\"text\"\n\t\t\t\t\t\t\t\tdata-color=\"#a0a0a0\"\n\t\t\t\t\t\t\t\tdata-rsp_ch=\"on\"\n\t\t\t\t\t\t\t\tdata-xy=\"x:24px;y:95px;\"\n\t\t\t\t\t\t\t\tdata-text=\"s:100;l:70;fw:300;\"\n\t\t\t\t\t\t\t\tdata-frame_0=\"tp:600;\"\n\t\t\t\t\t\t\t\tdata-frame_1=\"tp:600;sp:2300;sR:10;\"\n\t\t\t\t\t\t\t\tdata-frame_999=\"o:0;tp:600;st:5050;sp:970;sR:2740;\"\n\t\t\t\t\t\t\t\tstyle=\"z-index:5;font-family:'Impact', 'Charcoal', 'sans-serif';\"\n\t\t\t\t\t\t\t>1 \n\t\t\t\t\t\t\t<\/rs-layer><!--\n\n\t\t\t\t\t\t\t--><rs-layer\n\t\t\t\t\t\t\t\tid=\"slider-38-slide-119-layer-4\" \n\t\t\t\t\t\t\t\tdata-type=\"text\"\n\t\t\t\t\t\t\t\tdata-color=\"#606060\"\n\t\t\t\t\t\t\t\tdata-rsp_ch=\"on\"\n\t\t\t\t\t\t\t\tdata-xy=\"x:c;xo:-104px;y:115px;\"\n\t\t\t\t\t\t\t\tdata-text=\"s:18;l:22;ls:0px;fw:800;\"\n\t\t\t\t\t\t\t\tdata-dim=\"w:871px;h:123px;\"\n\t\t\t\t\t\t\t\tdata-frame_0=\"tp:600;\"\n\t\t\t\t\t\t\t\tdata-frame_1=\"tp:600;st:410;sp:3380;sR:410;\"\n\t\t\t\t\t\t\t\tdata-frame_999=\"o:0;tp:600;st:5470;sp:550;sR:1680;\"\n\t\t\t\t\t\t\t\tstyle=\"z-index:6;font-family:'Arial', 'Helvetica', 'sans-serif';\"\n\t\t\t\t\t\t\t>Nuevo anticuerpo monoclonal antialfasinucleina\nEnsayo Cl\u00ednico de fase II para evaluar eficacia y seguridad <br\/>en enfermedad de Parkinson inicial en pacientes que no reciben medicamentos antiparkinsonianos en el momento actual. \n\t\t\t\t\t\t\t<\/rs-layer><!--\n-->\t\t\t\t\t\t<\/rs-slide>\n\t\t\t\t\t\t<rs-slide style=\"position: absolute;\" data-key=\"rs-121\" data-title=\"Slide\" data-duration=\"7010\" data-anim=\"adpr:false;\">\n\t\t\t\t\t\t\t<img decoding=\"async\" src=\"\/\/udic.es\/wp-content\/plugins\/revslider\/public\/assets\/assets\/dummy.png\" alt=\"\" title=\"Activation of phase I trial in Progressive Supranuclear Palsy\" class=\"rev-slidebg tp-rs-img rs-lazyload\" data-lazyload=\"\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos2.jpg\" data-no-retina>\n<!--\n\t\t\t\t\t\t\t--><rs-layer\n\t\t\t\t\t\t\t\tid=\"slider-38-slide-121-layer-6\" \n\t\t\t\t\t\t\t\tclass=\"Gym-Display\"\n\t\t\t\t\t\t\t\tdata-type=\"text\"\n\t\t\t\t\t\t\t\tdata-color=\"#a0a0a0\"\n\t\t\t\t\t\t\t\tdata-rsp_ch=\"on\"\n\t\t\t\t\t\t\t\tdata-xy=\"x:24px;y:95px;\"\n\t\t\t\t\t\t\t\tdata-text=\"s:100;l:70;fw:300;\"\n\t\t\t\t\t\t\t\tdata-frame_0=\"tp:600;\"\n\t\t\t\t\t\t\t\tdata-frame_1=\"tp:600;sp:2300;sR:10;\"\n\t\t\t\t\t\t\t\tdata-frame_999=\"o:0;tp:600;st:6010;sp:970;sR:3700;\"\n\t\t\t\t\t\t\t\tstyle=\"z-index:5;font-family:'Impact', 'Charcoal', 'sans-serif';\"\n\t\t\t\t\t\t\t>2 \n\t\t\t\t\t\t\t<\/rs-layer><!--\n\n\t\t\t\t\t\t\t--><rs-layer\n\t\t\t\t\t\t\t\tid=\"slider-38-slide-121-layer-4\" \n\t\t\t\t\t\t\t\tdata-type=\"text\"\n\t\t\t\t\t\t\t\tdata-color=\"#606060\"\n\t\t\t\t\t\t\t\tdata-rsp_ch=\"on\"\n\t\t\t\t\t\t\t\tdata-xy=\"x:c;xo:-97px;y:99px;\"\n\t\t\t\t\t\t\t\tdata-text=\"s:18;l:22;ls:0px;fw:800;\"\n\t\t\t\t\t\t\t\tdata-dim=\"w:871px;h:123px;\"\n\t\t\t\t\t\t\t\tdata-frame_0=\"tp:600;\"\n\t\t\t\t\t\t\t\tdata-frame_1=\"tp:600;st:410;sp:3380;sR:410;\"\n\t\t\t\t\t\t\t\tdata-frame_999=\"o:0;tp:600;st:6050;sp:960;sR:2260;\"\n\t\t\t\t\t\t\t\tstyle=\"z-index:6;font-family:'Arial', 'Helvetica', 'sans-serif';\"\n\t\t\t\t\t\t\t>Nuevo f\u00e1rmaco antipsic\u00f3tico en cualquier tipo de demencia. \nEnsayo de Fase III que eval\u00faa un antipsic\u00f3tico <br\/>en cualquier tipo de delirio o alucinaciones. Sin acci\u00f3n antidopamin\u00e9rgica, especialmente indicado en Parkinson <br\/>o en situaciones de mala respuesta  a los neurolepticos \n\t\t\t\t\t\t\t<\/rs-layer><!--\n-->\t\t\t\t\t\t<\/rs-slide>\n\t\t\t\t\t<\/rs-slides>\n\t\t\t\t<\/rs-module>\n\t\t\t\t<script>\n\t\t\t\t\tsetREVStartSize({c: 'rev_slider_38_1',rl:[1240,1024,778,480],el:[],gw:[1240],gh:[300],type:'standard',justify:'',layout:'fullwidth',mh:\"0\"});if (window.RS_MODULES!==undefined && window.RS_MODULES.modules!==undefined && window.RS_MODULES.modules[\"revslider381\"]!==undefined) {window.RS_MODULES.modules[\"revslider381\"].once = false;window.revapi38 = undefined;if (window.RS_MODULES.checkMinimal!==undefined) window.RS_MODULES.checkMinimal()}\n\t\t\t\t<\/script>\n\t\t\t<\/rs-module-wrap>\n\t\t\t<!-- END REVOLUTION SLIDER -->\n\n","protected":false},"excerpt":{"rendered":"<p>Our Unit has achieved to be activated in this outstanding project and so serious pathology. We will participate in its development and also in a phase III.<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-9740","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.8.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Blog News - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/udic.es\/en\/blog-news\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Blog News - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\" \/>\n<meta property=\"og:url\" content=\"https:\/\/udic.es\/en\/blog-news\/\" \/>\n<meta property=\"og:site_name\" content=\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci%c3%b3-Cl%c3%adnica-447149502490430\/\" \/>\n<meta property=\"article:modified_time\" content=\"2019-11-08T08:46:58+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/udic.es\/en\/blog-news\/\",\"url\":\"https:\/\/udic.es\/en\/blog-news\/\",\"name\":\"Blog News - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\",\"isPartOf\":{\"@id\":\"https:\/\/udic.es\/#website\"},\"datePublished\":\"2019-01-22T13:18:29+00:00\",\"dateModified\":\"2019-11-08T08:46:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/udic.es\/en\/blog-news\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/udic.es\/en\/blog-news\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/udic.es\/en\/blog-news\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/udic.es\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Blog News\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/udic.es\/#website\",\"url\":\"https:\/\/udic.es\/\",\"name\":\"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\",\"description\":\"Unitat D&#039;Investigaci\u00f3 Cl\u00ednica\",\"publisher\":{\"@id\":\"https:\/\/udic.es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/udic.es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/udic.es\/#organization\",\"name\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\",\"url\":\"https:\/\/udic.es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/udic.es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png\",\"contentUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png\",\"width\":408,\"height\":123,\"caption\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\"},\"image\":{\"@id\":\"https:\/\/udic.es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci\u00f3-Cl\u00ednica-447149502490430\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Blog News - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/udic.es\/en\/blog-news\/","og_locale":"en_US","og_type":"article","og_title":"Blog News - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","og_url":"https:\/\/udic.es\/en\/blog-news\/","og_site_name":"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","article_publisher":"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci%c3%b3-Cl%c3%adnica-447149502490430\/","article_modified_time":"2019-11-08T08:46:58+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/udic.es\/en\/blog-news\/","url":"https:\/\/udic.es\/en\/blog-news\/","name":"Blog News - UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","isPartOf":{"@id":"https:\/\/udic.es\/#website"},"datePublished":"2019-01-22T13:18:29+00:00","dateModified":"2019-11-08T08:46:58+00:00","breadcrumb":{"@id":"https:\/\/udic.es\/en\/blog-news\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/udic.es\/en\/blog-news\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/udic.es\/en\/blog-news\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/udic.es\/en\/"},{"@type":"ListItem","position":2,"name":"Blog News"}]},{"@type":"WebSite","@id":"https:\/\/udic.es\/#website","url":"https:\/\/udic.es\/","name":"UDIC Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","description":"Unitat D&#039;Investigaci\u00f3 Cl\u00ednica","publisher":{"@id":"https:\/\/udic.es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/udic.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/udic.es\/#organization","name":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","url":"https:\/\/udic.es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/udic.es\/#\/schema\/logo\/image\/","url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png","contentUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png","width":408,"height":123,"caption":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica"},"image":{"@id":"https:\/\/udic.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci\u00f3-Cl\u00ednica-447149502490430\/"]}]}},"_links":{"self":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/pages\/9740","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/comments?post=9740"}],"version-history":[{"count":5,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/pages\/9740\/revisions"}],"predecessor-version":[{"id":10640,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/pages\/9740\/revisions\/10640"}],"wp:attachment":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/media?parent=9740"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}